-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
preface
prefaceOn August 17, 2022, Bluebird Bio announced that the U.
$2.
This means that the record of the world's most expensive drug has been broken again in just 30 days, and the latest sky-high drug king was born without the highest, only higher!
2.
2.
Zynteglo was approved for listing in the European Union in June 2019, but after disagreements with European health insurance companies on the selling price, it withdrew from the European market
According to Bluebird Biologics, patients with transfusion-dependent β-thalassemia have a lifetime treatment cost about $6.
In addition to being qualified for Priority Review (PR), Fast Track (FT), Breakthrough Therapies (BT) and orphan drugs, Zynteglo has also been recognized for
3 million records
3 million recordsOn September 16, 2022, Bluebird announced that the FDA has accelerated the approval of the company's gene therapy drug Skysona (elivaldogene autotemce, eli-cel) to slow the progression
It is reported that about 40 to 50 patients in the United States are diagnosed with CALD
Bluebird expects to treat about 10 patients
Mr.
On June 9-10 of this year, the FDA invited outside experts to a meeting of the Cell, Organization, and Gene Therapy Advisory Committee (CTGTAC) to discuss the listing applications
Research and development is not easy, and the company has faced difficult situations many times, including the eli-cel clinical development program has been clinically restricted
Resources:
Resources:$2.
$2.
Bluebird Biotech's second gene therapy was approved by the FDA and priced at $3 million
$3 million! The FDA approved the most expensive gene therapy ever to market
$3 million! The FDA approved the most expensive gene therapy ever to marketHigh ticket passed! On the first day of the FDA expert advisory committee, Bluebird Bio "successfully broke through", can they ease up this time?
High ticket passed! On the first day of the FDA expert advisory committee, Bluebird Bio "successfully broke through", can they ease up this time?Everything You Should Know About FDA Priority Review Vouchers!
Everything You Should Know About FDA Priority Review Vouchers!After two FDA expert advisory committees, the "stock price" of Bluebird Bio and CRISPR changed head-to-head.
After two FDA expert advisory committees, the "stock price" of Bluebird Bio and CRISPR changed head-to-head.
.
.
High ticket passed! On the first day of the FDA expert advisory committee, Bluebird Bio "successfully broke through", can they ease up this time?
High ticket passed! On the first day of the FDA expert advisory committee, Bluebird Bio "successfully broke through", can they ease up this time?Take your neighbor as a teacher | From LogicBio and Bluebird Biologics, how to avoid evil when encountering the FDA's clinical suspension ban?
Take your neighbor as a teacher | From LogicBio and Bluebird Biologics, how to avoid evil when encountering the FDA's clinical suspension ban? CFO submitted his resignation, funds are about to run out, and Bluebird Bio is in a worrying situation.
.
.
.
.
After the semi-annual report was released, gene therapy star company Bluebird Bio fell 27%
After the semi-annual report was released, gene therapy star company Bluebird Bio fell 27%
